FORTERIS WEALTH MANAGEMENT INC.

Position in LLY — ELI LILLY & Co

CIK 2107238 ARMONK, NY

Position in LLY

as of Jun 30, 2026 · filed Jul 21, 2026 Compact

Position Value

$2,473,224

+$544,467 QoQ

Shares Held

2,062

-1.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

5.92%

of 13F equity value

Holder Rank

#2,305

of 4,605 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

FORTERIS WEALTH MANAGEMENT INC. holds $4,184,332 across 4 Drug Manufacturers - General names. LLY ranks #1 (59.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co This page	2,062	$2,473,224
2	GILD	Gilead Sciences, Inc.	6,150	$776,991
3	JNJ	Johnson & Johnson	2,462	$625,274
4	BMY	Bristol Myers Squibb Co	5,360	$308,843

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,473,224	2,062	-1.7%	Shares	Sole	2026-07-21
2026-03-31	$1,928,757	2,097	-15.1%	Shares	Sole	2026-04-21
2025-12-31	$2,654,459	2,470	—	Shares	Sole	2026-01-26
No filing history on record for this holder in this stock.